China Pharma Holdings (CPHI) Work In Process (2017 - 2024)
China Pharma Holdings (CPHI) reported Work In Process of $334430.0 for Q3 2024, down 50.59% on a YoY basis from $676885.0 in Q4 2023, and up 283.05% quarter-over-quarter from $87308.0 in Q2 2024.
China Pharma Holdings (CPHI) Work In Process (2017 - 2024) Analysis & Trends
China Pharma Holdings has reported Work In Process for 8 years, with the latest figure at $334430.0 in Q3 2024.
- For the quarter ending Q3 2024, Work In Process fell 50.59% year-over-year to $334430.0; the trailing twelve-month figure through Sep 2024 stood at $334430.0 (down 50.59% YoY), and the FY2023 full-year result was $413597.0, down 25.77% from the prior year.
- Work In Process for Q3 2024 stood at $334430.0, up from $87308.0 in the prior quarter.
- The five-year high for Work In Process was $676885.0 in Q3 2023, with the low at $87308.0 in Q2 2024.
- Historically, Work In Process has averaged $431457.2 across 5 years, with a median of $423493.0 in 2020.
- Annual changes were most pronounced in 2020 — Work In Process surged 110.99% — and 2024, when it slumped 76.07%.
- China Pharma Holdings' Work In Process stood at $662999.0 in 2020, then fell by 15.97% to $557146.0 in 2021, then changed by 0.0% to $557146.0 in 2022, then decreased by 25.77% to $413597.0 in 2023, then retreated by 19.14% to $334430.0 in 2024.
- The last three Work In Process figures came in at $334430.0 (Q3 2024), $87308.0 (Q2 2024), and $242726.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | China Pharma Holdings | 18.87 Mn | 18.70 Mn | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 334,430.00 |
| Jun 30, 2024 | 87,308.00 |
| Mar 31, 2024 | 242,726.00 |
| Dec 31, 2023 | 413,597.00 |
| Sep 30, 2023 | 676,885.00 |
| Jun 30, 2023 | 364,913.00 |
| Mar 31, 2023 | 319,059.00 |
| Dec 31, 2022 | 557,146.00 |
| Sep 30, 2022 | 615,020.00 |
| Jun 30, 2022 | 356,702.00 |
| Dec 31, 2021 | 557,146.00 |
| Sep 30, 2021 | 442,022.00 |
| Jun 30, 2021 | 461,293.00 |
| Mar 31, 2021 | 341,269.00 |
| Dec 31, 2020 | 662,999.00 |
| Sep 30, 2020 | 433,389.00 |
| Jun 30, 2020 | 644,174.00 |
| Mar 31, 2020 | 256,151.00 |
| Dec 31, 2019 | 314,231.00 |
| Sep 30, 2019 | 382,900.00 |